RIMBP2 mRNA expression level correlates with the worst prognosis for lung squamous carcinoma patients and was found to be among 8 differentially expressed genes in lenvatinib-treated hepatocellular carcinoma [58,59]. This evidence concerns the gene RIMBP2 and hepatocellular carcinoma.